vimarsana.com

Page 25 - ஆரோக்கியம் அமைப்பு மருந்தாளுநர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AAMC Asks HHS Secretary to Stop Drug Companies Illegal 340B Actions

The AAMC and five other organizations representing hospitals and pharmacists sent a letter on April 20 to Health and Human Services (HHS) Secretary Xavier Becerra, JD, requesting that the HHS immediately take action to prevent six drug companies from refusing to provide hospitals with 340B discounts for drugs dispensed through community pharmacies (also known as “contract pharmacies”). The letter highlighted the importance of community pharmacies and requested that the “HHS immediately and definitively state that these refusals to provide discounts are illegal and take the action Congress specifically prescribed to address this type of situation impose civil money penalties.” The same organizations the AAMC, the American Hospital Association, 340B Health, America’s Essential Hospitals, the Children’s Hospital Association, and the American Society of Health-System Pharmacists previously filed a lawsuit after Eli Lilly and Co. and five other major drug manufacturers

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021 The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according to the ASHP s (American Society of Health-System Pharmacists) National Trends in Prescription Drug Expenditures and Projections for 2021. Shifts in care related to the pandemic will continue to be a significant driver of drug expenditures in 2021, along with uptake in the use of biosimilars, a large pipeline of new cancer drugs, and increased approvals of specialty medications. Prescription drug spending in 2020 grew at a moderate rate of 4.9% to $535.3 billion. Increased utilization drove the growth, which accounted for 2.9% of the total increase. Spending on new drugs accounted for 1.8% of the increase, and price changes accounted for 0.3%.

New report finds COVID-19 pandemic causes dramatic shifts in prescription drug spending

The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according to the ASHP s (American Society of Health-System Pharmacists) National Trends in Prescription Drug Expenditures and Projections for 2021. Shifts in care related to the pandemic will continue to be a significant driver of drug expenditures in 2021, along with uptake in the use of biosimilars, a large pipeline of new cancer drugs, and increased approvals of specialty medications.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.